Quantum Biopharma (QNTM) Other Income (2020 - 2026)
Quantum Biopharma (QNTM) posted Other Income of $122998.0 for Q1 2026, up 47.23% sequentially from $83544.0 in Q2 2025, and up 3622.28% YoY from $3304.4 in Q1 2025.
Quantum Biopharma (QNTM) Other Income (2020 - 2026) Analysis & Trends
Quantum Biopharma has reported Other Income for 7 years, with the latest figure at $122998.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Quantum Biopharma | 15.44 Mn | 11.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 122,998.00 |
| Jun 30, 2025 | 83,544.00 |
| Mar 31, 2025 | -3,492.00 |
| Jun 30, 2024 | -101,089.00 |
| Mar 31, 2024 | -232,755.00 |
| Jun 30, 2023 | -232,891.00 |
| Mar 31, 2023 | 15,402.00 |
| Mar 31, 2022 | -73,585.00 |
| Sep 30, 2021 | 125,570.00 |
| Jun 30, 2021 | -41,948.00 |
| Mar 31, 2021 | -37,370.00 |
| Sep 30, 2020 | -271,770.43 |
| Jun 30, 2020 | 1.17 Mn |